Search Orphan Drug Designations and Approvals
-
Generic Name: | Darinaparsin |
---|---|
Date Designated: | 09/13/2010 |
Orphan Designation: | Treatment of peripheral T-cell lymphoma. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Solasia Pharma K.K. 3F, Shiodome Building Toyko 105-0022 Japan The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-